HomeSPRO • NASDAQ
add
Spero Therapeutics Inc
Previous close
$1.28
Day range
$1.27 - $1.35
Year range
$0.99 - $1.89
Market cap
74.05M USD
Avg Volume
120.18K
P/E ratio
4.13
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 10.20M | 275.44% |
Operating expense | 5.53M | -9.24% |
Net income | -17.86M | -49.92% |
Net profit margin | -175.17 | 60.07% |
Earnings per share | -0.33 | -43.48% |
EBITDA | -19.06M | -49.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 63.53M | -18.23% |
Total assets | 149.88M | 51.57% |
Total liabilities | 69.38M | 57.32% |
Total equity | 80.50M | — |
Shares outstanding | 54.05M | — |
Price to book | 0.86 | — |
Return on assets | -30.01% | — |
Return on capital | -50.98% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -17.86M | -49.92% |
Cash from operations | -18.74M | -0.97% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -18.74M | -0.97% |
Free cash flow | -6.80M | 60.02% |
About
Founded
2013
Website
Employees
46
